During this period, a study discovered that downregulation of CBX2 inhibits the aggressiveness of colorectal cancer cells.9 However, it is also the study of Zhou et al that demonstrates, on the other hand, the reliability of some of the cellular assay results in this study. The gene discussed is CBX2; the disease is colorectal cancer.